Gaurav Shah Rocket Pharmaceuticals, Inc. (RCKT) insider trading activity

RCKT Quotes by TradingView

Gaurav Shah is CEO of ROCKET PHARMACEUTICALS, INC.. Currently has a direct ownership of 784,572 shares of RCKT, which is worth approximately $2.53 Million. The most recent transaction as insider was on Mar 31, 2021, when has been sold 75,880 shares (Common Stock) at a price of $1.69 per share, resulting in proceeds of $128,237. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 785K
0.28% 3M change
9.21% 12M change
Total Value Held $2.53 Million

Gaurav Shah Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 31 2021
BUY
Exercise of conversion of derivative security
$128,237 $1.69 p/Share
75,880 Added 11.02%
612,751 Common Stock
Mar 30 2021
SELL
Payment of exercise price or tax liability
$3,710,362 $43.2 p/Share
85,888 Reduced 13.79%
536,871 Common Stock

Also insider at

TALS
Talaris Therapeutics, Inc. Healthcare
Director
GS

Gaurav Shah

CEO
Cranbury, NJ

Track Institutional and Insider Activities on RCKT

Follow ROCKET PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RCKT shares.

Notify only if

Insider Trading

Get notified when an Rocket Pharmaceuticals, Inc. insider buys or sells RCKT shares.

Notify only if

News

Receive news related to ROCKET PHARMACEUTICALS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RCKT